Next-Generation Sequencing Assays for Biomarker Analysis of Solid Tumors
Pioneer the path toward precision oncology—from preclinical to companion diagnostic development
The discovery of genetic biomarkers and their subsequent application in oncology research are paving the path toward targeted therapy development and selection, linking genes to disease states and prognosis, and, ultimately, more effective treatments. Our next-generation sequencing assays and bioinformatics and reporting products offer powerful options to support your efforts—from preclinical to companion diagnostic development.
Learn more from a member of our team by completing the form below.
*For Research Use Only. Not for use in diagnostic procedures.